Preferred Label : adamantane;

MeSH definition : A tricyclo bridged hydrocarbon.;

MeSH synonym : diamantane;

MeSH CAS label : Tricyclo(3.3.1.1(3,7))decane;

MeSH Related Number : 281-23-2 (Adamantane);

Registry Number MeSH : 281-23-2;

MeSH annotation : a cycloparaffin;

Wikipedia link : https://en.wikipedia.org/wiki/Adamantane;

Codes EINECS : 206-001-4;

Is substance : O;

UNII : PJY633525U;

InChIKey : ORILYTVJVMAKLC-UHFFFAOYSA-N;

Details


Main resources

You can consult :

A tricyclo bridged hydrocarbon.

https://www.has-sante.fr/jcms/p_3283452/fr/onglyza-saxagliptine-chlorhydrate-de
2021
false
false
false
France
evaluation of the transparency committee
saxagliptin
dipeptides
adamantane
treatment outcome
administration, oral
diabetes mellitus, type 2
Saxagliptin Hydrochloride
hypoglycemic agents
incretins
dipeptidyl-peptidase iv inhibitors
saxagliptin
drug therapy, combination
insurance, health, reimbursement

---
https://www.has-sante.fr/jcms/p_3283449/fr/komboglyze-metformine-/-saxagliptine
2021
false
false
false
France
evaluation of the transparency committee
saxagliptin
metformin
dipeptides
adamantane
metformin and saxagliptin
treatment outcome
insurance, health, reimbursement
drug combinations
Saxagliptin Hydrochloride
Metformin Hydrochloride
diabetes mellitus, type 2
hypoglycemic agents
drug therapy, combination
administration, oral
adult
incretins
dipeptidyl-peptidase iv inhibitors

---
https://www.ema.europa.eu/en/medicines/human/EPAR/qtrilmet
2019
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug combinations
metformin
dapagliflozin
saxagliptin
Metformin Hydrochloride
Metformin Hydrochloride
hypoglycemic agents
hypoglycemic agents
drug approval
europe
metformin, saxagliptin and dapagliflozin
diabetes mellitus, type 2
adult
administration, oral
incretins
incretins
dipeptidyl-peptidase iv inhibitors
dipeptidyl-peptidase iv inhibitors
Sodium-Glucose Transporter 2 Inhibitors
Sodium-Glucose Transporter 2 Inhibitors
Glycated Hemoglobin
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
dapagliflozin
metformin
dapagliflozin
saxagliptin
dapagliflozin
dipeptides
adamantane
glucosides
benzhydryl compounds
dapagliflozin
dipeptides
glucosides
benzhydryl compounds

---
https://www.revmed.ch/RMS/2016/RMS-N-527/Combinaison-gliptine-gliflozine-dans-le-traitement-du-diabete-de-type-2
2016
false
false
false
Switzerland
French
journal article
diabetes mellitus, type 2
drug combinations
hypoglycemic agents
dipeptidyl-peptidase iv inhibitors
SGLT2 Inhibitor
treatment outcome
saxagliptin and dapagliflozin
dapagliflozin
saxagliptin
Linagliptin
linagliptin and empagliflozin
empagliflozin
Product containing empagliflozin and linagliptin (medicinal product)
administration, oral
Sodium-Glucose transporter 2
Sodium-Glucose Transporter 2 Inhibitors
dapagliflozin
dapagliflozin
dipeptides
adamantane
adamantane
benzhydryl compounds
glucosides

---
https://www.ema.europa.eu/medicines/human/EPAR/qtern
2016
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
drug combinations
dapagliflozin
dapagliflozin
saxagliptin and dapagliflozin
saxagliptin
saxagliptin
adult
diabetes mellitus, type 2
administration, oral
Sodium-Glucose transporter 2
incretins
incretins
dipeptidyl-peptidase iv inhibitors
dipeptidyl-peptidase iv inhibitors
product surveillance, postmarketing
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
Sodium-Glucose Transporter 2 Inhibitors
dapagliflozin
dapagliflozin
dapagliflozin
glucosides
benzhydryl compounds
glucosides
benzhydryl compounds
dipeptides
adamantane
adamantane
dipeptides
adamantane

---
Summary Safety Review - Incretin-Based Therapies - Assessing the Potential Risk of Pancreatic Cancer
http://www.hc-sc.gc.ca/dhp-mps/medeff/reviews-examens/incretin-fra.php
2016
false
false
false
Canada
French
English
diabetes mellitus, type 2
pharmacovigilance note
incretins
pancreatic neoplasms
risk
saxagliptin
alogliptin
hypoglycemic agents
Sitagliptin Phosphate
Liraglutide
drug evaluation
risk assessment
canada
peptides
venoms
adamantane
adamantane
dipeptides
piperidines
uracil
uracil
Exenatide

---
https://www.cadth.ca/sites/default/files/pdf/E0007_vildagliptin_edrug_f.pdf
Canada
French
hypoglycemic agents
diabetes mellitus, type 2
drug evaluation
clinical trials as topic
hypoglycemic agents
adamantane
vildagliptin
drug evaluation
Product containing glucagon-like peptide 1 receptor agonist (product)
Substance with glucagon-like peptide 1 receptor agonist mechanism of action (substance)
Vildagliptin

---
http://www.prescrire.org/Fr/101/325/47324/0/PositionDetails.aspx
2011
false
false
false
France
French
drug information
hypoglycemic agents
administration, oral
Drug-Related side effects and adverse reactions
metformin
sulfonylurea compounds
saxagliptin
blood glucose lowering drugs, excl. insulins
Sitagliptin Phosphate
Liraglutide
glucagon-like peptide 1
glucagon-like peptide 1
peptides
venoms
adamantane
adamantane
nitriles
pyrrolidines
dipeptides
Exenatide
Vildagliptin

---
Nous contacter.
13/06/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.